Microvast’s tale reads like a cleantech thriller: Yang Wu’s contrarian 2006 bet on ultra‑fast, long‑life batteries for buses turned into serious scale in China, a high‑profile SPAC debut and big investor backing — then into a bruising public‑market reality of short‑seller attacks, delayed U.S. factory plans, a canceled DOE award, and steep losses that nearly sank the company. Against those odds Microvast has quietly tightened execution: revenue and margins have improved, Q1 2025 showed record revenue and the company even posted a quarterly profit, and it’s now juggling global manufacturing, a broadened chemistry lineup and ambitious solid‑state research. The result is a clear split between promise and peril — an underdog with meaningful IP and a “Made in America” narrative wrestling with giants, geopolitics and capital intensity — making Microvast one of the most compelling, high‑risk stories in the battery wars.

Transcript - https://empor.top/us/MVST

• I. Introduction & Episode Roadmap
• II. Founder Origins & The First Battery Dream (2006–2010)
• III. The Inflection Point: Winning in Chinese Electric Buses (2010–2016)
• IV. Going West: The Shift to Europe & America (2016–2019)
• V. The SPAC Boom and Tuscan Holdings Merger (2020–2021)
• VI. The Trough of Sorrow: Execution Challenges & Market Reality (2021–2023)
• VII. The Pivot & Recent Developments: Survival Mode to Strategic Bets (2023–2025)
• VIII. Playbook: What Microvast Teaches About Battery Businesses
• IX. Porter's 5 Forces & Hamilton's 7 Powers Analysis
• X. Bull vs. Bear Case & Investment Framework
• XI. Epilogue: The Future of Microvast & The Battery Wars